These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 24836405)

  • 1. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
    Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study.
    Miró J; Toledo M; Santamarina E; Ricciardi AC; Villanueva V; Pato A; Ruiz J; Juvany R; Falip M
    Seizure; 2013 Jan; 22(1):77-9. PubMed ID: 23127776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
    Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous lacosamide in status epilepticus and seizure clusters.
    Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
    Epilepsia; 2011 Oct; 52(10):e148-52. PubMed ID: 21801171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
    Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
    Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
    Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N
    Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review.
    Hawkes MA; Fernández Suárez M; Ugarnes G; D'Giano C
    Clin Neuropharmacol; 2013; 36(4):138-40. PubMed ID: 23860347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
    Kellinghaus C; Berning S; Stögbauer F
    Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study.
    Belcastro V; Vidale S; Pierguidi L; Sironi L; Tancredi L; Striano P; Taborelli A; Arnaboldi M
    Seizure; 2013 Dec; 22(10):905-7. PubMed ID: 23953988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center.
    Synowiec AS; Yandora KA; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2012 Feb; 98(2-3):232-7. PubMed ID: 22000869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacosamide as a new treatment option in status epilepticus.
    Höfler J; Trinka E
    Epilepsia; 2013 Mar; 54(3):393-404. PubMed ID: 23293881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ketogenic diet in the treatment of refractory status epilepticus.
    Nam SH; Lee BL; Lee CG; Yu HJ; Joo EY; Lee J; Lee M
    Epilepsia; 2011 Nov; 52(11):e181-4. PubMed ID: 22003821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clobazam: An effective add-on therapy in refractory status epilepticus.
    Sivakumar S; Ibrahim M; Parker D; Norris G; Shah A; Mohamed W
    Epilepsia; 2015 Jun; 56(6):e83-9. PubMed ID: 25963810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
    Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
    Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine use in the treatment of refractory status epilepticus.
    Synowiec AS; Singh DS; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2013 Jul; 105(1-2):183-8. PubMed ID: 23369676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of refractory status epilepticus at a tertiary care centre in a developing country.
    Tripathi M; Vibha D; Choudhary N; Prasad K; Srivastava MV; Bhatia R; Chandra SP
    Seizure; 2010 Mar; 19(2):109-11. PubMed ID: 20034814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous lacosamide in clinical practice-Results from an independent registry.
    Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U
    Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
    Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
    Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.